Tingholo, Celsa .

HRN: 01-06-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CO-AMOXICLAV 625MG (TAB)
06/21/2025
06/28/2025
PO
625mg
BID
Gingivitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: